UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2014
Commission File Number 001-33042
ROSETTA GENOMICS LTD.
(Translation of registrant’s name into English)
10 Plaut Street, Science Park
Rehovot 76706, Israel
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F þ Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ROSETTA GENOMICS LTD. | ||
Date: October 24, 2014 | By: | /s/ Oded Biran |
Oded Biran | ||
General Counsel and Secretary |
Exhibit Index
Exhibit | ||
Number | Description of Exhibit | |
99.1 | Response of Rosetta Genomics Ltd. to the shareholder position paper regarding the annual general meeting of shareholders of Rosetta Genomics Ltd. to be held on November 5, 2014. | |
99.2 | Shareholder position paper regarding the annual general meeting of shareholders of Rosetta Genomics Ltd. to be held on November 5, 2014. |